{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:22:26Z","timestamp":1793226146284,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR22881 and BT\/PR22985"],"award-info":[{"award-number":["BT\/PR22881 and BT\/PR22985"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/000092"],"award-info":[{"award-number":["CRG\/000092"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DST INSPIRE"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2024,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There are a limited number of effective vaccines against dengue virus (DENV) and significant efforts are being made to develop potent anti-virals. Previously, we described that platelet-chemokine CXCL4 negatively regulates interferon (IFN)-\u03b1\/\u03b2 synthesis and promotes DENV2 replication. An antagonist to CXCR3 (CXCL4 receptor) reversed it and inhibited viral replication. In a concurrent search, we identified CXCR3-antagonist from our compound library, namely 7D, which inhibited all serotypes of DENV in vitro. With a half-life of ~2.85\u2009h in plasma and no significant toxicity, 7D supplementation (8\u2009mg\/kg-body-weight) to DENV2-infected IFN\u03b1\/\u03b2\/\u03b3R\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    AG129 or wild-type C57BL6 mice increased synthesis of IFN-\u03b1\/\u03b2 and IFN-\u03bb, and rescued disease symptoms like thrombocytopenia, leukopenia and vascular-leakage, with improved survival. 7D, having the property to inhibit Sirt-1 deacetylase, promoted acetylation and phosphorylation of STAT3, which in-turn increased plasmablast proliferation, germinal-center maturation and synthesis of neutralizing-antibodies against DENV2 in mice. A STAT3-inhibitor successfully inhibited these effects of 7D. Together, these observations identify compound 7D as a stimulator of IFN-\u03b1\/\u03b2\/\u03bb synthesis via CXCL4:CXCR3:p38:IRF3 signaling, and a booster for neutralizing-antibody generation by promoting STAT3-acetylation in plasmablasts, capable of protecting dengue infection.\n                  <\/jats:p>","DOI":"10.1038\/s44321-024-00137-8","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T06:02:31Z","timestamp":1726466551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5615-6221","authenticated-orcid":false,"given":"Kishan Kumar","family":"Gaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6745-9682","authenticated-orcid":false,"given":"Tejeswara Rao","family":"Asuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitul","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikil","family":"Purushotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boja","family":"Poojary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabatosh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-8460","authenticated-orcid":false,"given":"Sankar","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-7500","authenticated-orcid":false,"given":"Shailendra","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-6692","authenticated-orcid":false,"given":"Prasenjit","family":"Guchhait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"137_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0166-3542(94)90058-2","volume":"24","author":"S Baron","year":"1994","unstructured":"Baron S, Dianzani F (1994) The interferons: a biological system with therapeutic potential in viral infections. Antiviral Res 24:97\u2013110","journal-title":"Antiviral Res"},{"key":"137_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O et al (2013) The global distribution and burden of dengue. Nature 496:504\u2013507","journal-title":"Nature"},{"key":"137_CR3","doi-asserted-by":"publisher","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","volume":"6","author":"OJ Brady","year":"2012","unstructured":"Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI (2012) Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 6:e1760","journal-title":"PLoS Negl Trop Dis"},{"key":"137_CR4","unstructured":"Case DA, Aktulga HM, Belfon K, Ben-Shalom IY, Berryman JT, Brozell SR, Cerutti DS, Cheatham TE III, Cisneros GA, Cruzeiro VWD et al (2022) AMBER 22 reference manual. University of California, San Francisco, CA"},{"key":"137_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12879-015-1022-9","volume":"15","author":"Cucunawangsih","year":"2015","unstructured":"Cucunawangsih, Lugito NPH, Kurniawan A (2015) Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset. BMC Infect Dis 15:276\u2013281","journal-title":"BMC Infect Dis"},{"key":"137_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S et al (2010) Screaton, cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745\u2013748","journal-title":"Science"},{"key":"137_CR7","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1021\/acs.jctc.5b00648","volume":"11","author":"M Di Pierro","year":"2015","unstructured":"Di Pierro M, Elber R, Leimkuhler B (2015) A stochastic algorithm for the isobaric-isothermal ensemble with ewald summations for all long range forces. J Chem Theory Comput 11:5624\u20135637","journal-title":"J Chem Theory Comput"},{"key":"137_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12879-015-1271-7","volume":"15","author":"R Fragnoud","year":"2015","unstructured":"Fragnoud R, Flamand M, Reynier F, Buchy P, Duong V, Pachot A, Paranhos-Baccala G, Bedin F (2015) Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue. BMC Infect Dis 15:518\u2013531","journal-title":"BMC Infect Dis"},{"key":"137_CR9","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/ATVBAHA.108.169417","volume":"28","author":"CA Gleissner","year":"2008","unstructured":"Gleissner CA, Hundelshausen PV, Ley K (2008) Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 28:1920\u20131927","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"137_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","volume":"158","author":"MG Guzman","year":"2013","unstructured":"Guzman MG, Alvarez M, Halstead SB (2013) Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158:1445\u20131459","journal-title":"Arch Virol"},{"key":"137_CR11","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"137_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4049\/jimmunol.177.3.1855","volume":"177","author":"MF Hsieh","year":"2006","unstructured":"Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F (2006) Both CXCR3 and CXCL10\/IFN- inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol 177:1855\u20131863","journal-title":"J Immunol"},{"key":"137_CR13","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.4049\/jimmunol.0903484","volume":"184","author":"PP Ip","year":"2010","unstructured":"Ip PP, Liao F (2010) Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. J Immunol 184:5705\u20135714","journal-title":"J Immunol"},{"key":"137_CR14","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.2149\/tmh.2011-S10","volume":"39","author":"S Kalayanarooj","year":"2011","unstructured":"Kalayanarooj S (2011) Clinical manifestations and management of dengue\/DHF\/DSS. Trop Med Health 39:S83\u2013S87","journal-title":"Trop Med Health"},{"issue":"8","key":"137_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4161\/cc.5.8.2690","volume":"5","author":"U Kolthur-Seetharam","year":"2006","unstructured":"Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia G, Sassone-Corsi P (2006) Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 5(8):873\u20137","journal-title":"Cell Cycle"},{"key":"137_CR16","doi-asserted-by":"publisher","first-page":"pdb.prot 095505","DOI":"10.1101\/pdb.prot095505","volume":"2018","author":"P Kumar","year":"2018","unstructured":"Kumar P, Nagarajan A, Uchil PD (2018) Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc 2018:pdb.prot 095505","journal-title":"Cold Spring Harb Protoc"},{"key":"137_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.658312","volume":"8","author":"A Kumari","year":"2021","unstructured":"Kumari A, Mittal L, Srivastava M, Pathak DP, Asthana S (2021) Conformational characterization of the co-activator binding site revealed the mechanism to achieve the bioactive state of FXR. Front Mol Biosci 8:658312","journal-title":"Front Mol Biosci"},{"key":"137_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1172\/JCI115457","volume":"88","author":"I Kurane","year":"1991","unstructured":"Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA (1991) Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Investig 88:1473\u20131480","journal-title":"J Clin Investig"},{"key":"137_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.celrep.2017.04.004","volume":"19","author":"E Limagne","year":"2017","unstructured":"Limagne E, Thibaudin M, Euvrard R, Berger H, Chalons P, V\u00e9gan F, Humblin E, Boidot R, R\u00e9b\u00e9 C, Derang\u00e8re V et al (2017) Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation. Cell Rep 19:746\u2013759","journal-title":"Cell Rep"},{"key":"137_CR20","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","volume":"144","author":"R Littaua","year":"1990","unstructured":"Littaua R, Kurane I, Ennis FA (1990) Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144:3183\u20133186","journal-title":"J Immunol"},{"key":"137_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cei\/uxad007","volume":"212","author":"J Mackie","year":"2023","unstructured":"Mackie J, Ma CS, Tangye SG, Guerin A (2023) The ups and downs of STAT3 function: too much, too little and human immune dysregulation. Clin Exp Immunol 212:107\u2013116","journal-title":"Clin Exp Immunol"},{"key":"137_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jcv.2013.10.023","volume":"58","author":"GN Malavige","year":"2013","unstructured":"Malavige GN, Ogg GS (2013) T cell responses in dengue viral infections. J Clin Virol 58:605\u2013611","journal-title":"J Clin Virol"},{"key":"137_CR23","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1080\/07391102.2020.1768151","volume":"39","author":"L Mittal","year":"2021","unstructured":"Mittal L, Kumari A, Srivastava M, Singh M, Asthana S (2021a) Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. J Biomol Struct Dyn 39:3662\u20133680","journal-title":"J Biomol Struct Dyn"},{"key":"137_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.109059","volume":"713","author":"L Mittal","year":"2021","unstructured":"Mittal L, Tonk RK, Awasthi A, Asthana A (2021b) Targeting cryptic-orthosteric site of PD-L1 for inhibitor identification using structure-guided approach. Arch Biochem Biophys 713:109059","journal-title":"Arch Biochem Biophys"},{"key":"137_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ebiom.2018.11.049","volume":"39","author":"A Ojha","year":"2019","unstructured":"Ojha A, Bhasym A, Mukherjee S, Annarapu GK, Bhakuni T, Akbar I, Seth T, Vikram NK, Vrati S, Basu A et al (2019) Platelet factor 4 promotes rapid replication and propagation of dengue and Japanese encephalitis viruses. EBioMed 39:332\u2013347","journal-title":"EBioMed"},{"key":"137_CR26","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1021\/acsomega.7b01512","volume":"3","author":"S Patil","year":"2018","unstructured":"Patil S, Kuman MM, Palvai S, Sengupta P, Basu S (2018) Impairing powerhouse in colon cancer cells by hydrazide-hydrazone-based small molecule. ACS Omega 3:1470\u20131481","journal-title":"ACS Omega"},{"key":"137_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.actatropica.2018.10.017","volume":"190","author":"G Patra","year":"2019","unstructured":"Patra G, Mallik S, Saha B, Mukhopadhyay S (2019) Assessment of chemokine and cytokine signatures in patients with dengue infection: a hospital-based study in Kolkata, India. Acta Tropica 190:73\u201379","journal-title":"Acta Tropica"},{"key":"137_CR28","doi-asserted-by":"publisher","first-page":"13431","DOI":"10.3390\/ijms241713431","volume":"24","author":"DV Petrovskiy","year":"2023","unstructured":"Petrovskiy DV, Nikolsky KS, Rudnev VR, Kulikova LI, Butkova TV, Malsagova KA, Kopylov AT, Kaysheva AL (2023) Modeling side chains in the three-dimensional structure of proteins for post-translational modifications. Int J Mol Sci 24:13431","journal-title":"Int J Mol Sci"},{"key":"137_CR29","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1128\/CVI.05278-11","volume":"18","author":"HE Prince","year":"2011","unstructured":"Prince HE, Yeh C, Lap\u00e9-Nixon M (2011) Utility of IgM\/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset. Clin Vaccine Immunol 18:1951\u20131956","journal-title":"Clin Vaccine Immunol"},{"key":"137_CR30","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1039\/D1RA06149F","volume":"12","author":"N Purushotham","year":"2022","unstructured":"Purushotham N, Singh M, Paramesha B, Kumar V, Wakode S, Banerjee SK, Poojary B, Asthana S (2022) Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors. RSC Adv 12:3809\u20133827","journal-title":"RSC Adv"},{"key":"137_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681950","volume":"12","author":"AP Rathore","year":"2021","unstructured":"Rathore AP, Mantri CK, Tan MW, Shirazi R, Nishida A, Aman SA, Morrison J, St John AL (2021) Immunological and pathological landscape of dengue serotypes 1-4 infections in immune-competent mice. Front Immunol 12:681950","journal-title":"Front Immunol"},{"key":"137_CR32","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","volume":"15","author":"K Roos","year":"2019","unstructured":"Roos K, Wu C, Damm W, Reboul M, Stevenson JM, Lu C, Dahlgren MK, Mondal S, Chen W, Wang L (2019) OPLS3e: extending force field coverage for drug-like small molecules. J Chem Theory Comput 15:1863\u20131874","journal-title":"J Chem Theory Comput"},{"key":"137_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3014","volume":"11","author":"A Rothman","year":"2011","unstructured":"Rothman A (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11:532\u2013543","journal-title":"Nat Rev Immunol"},{"key":"137_CR34","doi-asserted-by":"publisher","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","volume":"33","author":"VV Sarathy","year":"2015","unstructured":"Sarathy VV, Milligan GN, Bourne N, Barrett AD (2015) Mouse models of dengue virus infection for vaccine testing. Vaccine 33:7051\u20137060","journal-title":"Vaccine"},{"key":"137_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234","journal-title":"J Comput Aided Mol Des"},{"key":"137_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.micinf.2013.10.011","volume":"16","author":"B Sierra","year":"2014","unstructured":"Sierra B, Perez AB, Garcia G, Aguirre E, Alvarez M, Gonzalez D, Guzman MG (2014) Role of CC chemokine receptor 1 and two of its ligands in human dengue infection. Three approaches under the Cuban situation. Microb Infect 16:40\u201350","journal-title":"Microb Infect"},{"key":"137_CR37","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"CP Simmons","year":"2012","unstructured":"Simmons CP, Farrar JJ, Chau NV, Wills B (2012) Dengue. New Engl J Med 366:1423\u20131432","journal-title":"New Engl J Med"},{"key":"137_CR38","doi-asserted-by":"publisher","first-page":"34289","DOI":"10.18632\/oncotarget.26136","volume":"9","author":"M Srivastava","year":"2018","unstructured":"Srivastava M, Suri C, Singh M, Mathur R, Asthana S (2018) Molecular dynamics simulation reveals the possible druggable of USP7. Oncotarget 9:34289\u201334305","journal-title":"Oncotarget"},{"key":"137_CR39","doi-asserted-by":"publisher","first-page":"e00481","DOI":"10.7554\/eLife.00481","volume":"2","author":"AL St John","year":"2013","unstructured":"St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN (2013) Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. eLife 2:e00481","journal-title":"eLife"},{"key":"137_CR40","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1371\/journal.pntd.0000672","volume":"4","author":"GK Tan","year":"2010","unstructured":"Tan GK, Ng JK, Trasti SL, Schul W, Yip G, Alonso S (2010) A non-mouse adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS negl Trop Dis 4:e672","journal-title":"PLoS negl Trop Dis"},{"key":"137_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.1241475","volume":"341","author":"Q Tan","year":"2013","unstructured":"Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, Li T, Ma L, Fenalti G, Li J et al (2013) Structure of the CCR5 chemokine receptor\u2013HIV entry inhibitor maraviroc complex. Science 341:1387\u20131390","journal-title":"Science"},{"key":"137_CR42","doi-asserted-by":"publisher","first-page":"e1006385","DOI":"10.1371\/journal.ppat.1006385","volume":"13","author":"MRO Trugilho","year":"2017","unstructured":"Trugilho MRO, Hottz ED, Brunoro GVF, Teixeira-Ferreira A, Carvalho PC, Salazar GA, Zimmerman GA, Bozza FA, Bozza PT, Perales J (2017) Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue. PLoS Pathog 13:e1006385","journal-title":"PLoS Pathog"},{"key":"137_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","volume":"16","author":"A Wack","year":"2015","unstructured":"Wack A, Terczy\u0144ska-Dyla E, Hartmann R (2015) Guarding the frontiers: the biology of type III interferons. Nat Immunol 16:802\u2013809","journal-title":"Nat Immunol"},{"key":"137_CR44","doi-asserted-by":"publisher","first-page":"22378","DOI":"10.1002\/jcp.28803","volume":"234","author":"X Wang","year":"2019","unstructured":"Wang X, Zhao Z, Zhu K, Bao R, Meng Y, Bian J, Wan X, Yang T (2019) Effects of CXCL4\/CXCR3 on the lipopolysaccharide-induced injury in human umbilical vein endothelial cells. J Cell Physiol 234:22378\u201322385","journal-title":"J Cell Physiol"},{"key":"137_CR45","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.4269\/ajtmh.17-0948","volume":"99","author":"MC Whiteman","year":"2018","unstructured":"Whiteman MC, Bogardus L, Giacone DG, Rubinstein LJ, Antonello JM, Sun D, Daijogo S, Gurney KB (2018) Virus reduction neutralization test: a single-cell imaging high-throughput virus neutralization assay for dengue. Am J Trop Med Hyg 99:1430\u20131439","journal-title":"Am J Trop Med Hyg"},{"key":"137_CR46","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/cmdc.200700365","volume":"3","author":"M Wijtmans","year":"2008","unstructured":"Wijtmans M, Verzijl D, Leurs R, de Esch IJ, Smit MJ (2008) Towards small\u2010molecule CXCR3 ligands with clinical potential. ChemMedChem 3:861\u2013872","journal-title":"ChemMedChem"},{"key":"137_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/v14010090","volume":"14","author":"ED Yu","year":"2022","unstructured":"Yu ED, Wang H, da Silva Antunes R, Tian Y, Tippalagama R, Alahakoon SU, Premawansa G, Wijewickrama A, Premawansa S, De Silva AD et al (2022) A population of CD4+ CD8+ double-positive T cells associated with risk of plasma leakage in dengue viral infection. Viruses 14:90","journal-title":"Viruses"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00137-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:07:36Z","timestamp":1786028856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,14]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00137-8","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"30 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"9"}}